Brazilian_Controlled_Drugs_and_Substances_Act

Brazilian Controlled Drugs and Substances Act

Brazilian Controlled Drugs and Substances Act

Brazil's federal drug control statute

The Brazilian Controlled Drugs and Substances Act (Portuguese: Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial), officially Portaria nº 344/1998,[1] is Brazil's federal drug control statute, issued by the Ministry of Health through its National Health Surveillance Agency (Anvisa). The act also serves as the implementing legislation for the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances in the country.

The list was last updated in September 2023.[2]

Terminology:

  • Prescription notification - a standardized document intended for notifying Anvisa of the prescription of medications. Written by the doctor and retained by the drugstore
  • Prescription - a written medication order that provides usage instructions for the patient.
  • Special control prescription - a prescrition that is filled out in two copies, one that is retained by the drugstore, and another stays with the patient for usage guidance. It can be provided in a digital signed form.[3]

Overview

More information Class, Type of substance ...

Alemerian Aldyhyde

Class A3

Class A1

Class A2

Class A3

Class B1

Class B2

Class C1

Class C2

Class C3

Class C4

List revoked in September 2016.[6]

Class C5

Class D

Class D1

Class D2

Class E

Class F

Class F1

Class F2

Class F3

Class F4

References

  1. [1]
    ANVISA. "Portaria n.o 344, de 12 de maio de 1998" (PDF). Archived from the original (PDF) on 12 July 2017. Retrieved 19 July 2017.
  2. [2]
    Anvisa (2023-09-15). "RDC Nº 816 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 816 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-09-18). Archived from the original on 2023-10-19. Retrieved 2023-10-19.
  3. [3]
    Rodrigo, Kleber (2020-03-26). "Medicamentos controlados: receitas com assinatura digital". Abcfarma (in Brazilian Portuguese). Archived from the original on 2023-08-16. Retrieved 2023-08-16.
  4. [4]
    Vigilância Sanitária de Fortaleza (April 2017). "Orientações para prescrição de medicamentos sujeitos a controle especial" (PDF). Conselho Regional de Farmácia do Estado do Ceará. Archived (PDF) from the original on 2022-02-22. Retrieved 2023-08-15.
  5. [5]
    Anvisa (2011-03-22). "Dispõe sobre o controle da substância Talidomida e do medicamento que a contenha". Biblioteca Virtual em Saúde MS (in Brazilian Portuguese). Archived from the original on 2022-08-18. Retrieved 2023-08-15.
  6. [6]
    Anvisa (2016-08-31). "RDC Nº 103 Control" (in Brazilian Portuguese). Diário Oficial da União (published 2016-09-01). Archived from the original on 2023-08-03. Retrieved 2023-08-03.
Share this article:

This article uses material from the Wikipedia article Brazilian_Controlled_Drugs_and_Substances_Act, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.